| Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND) (NCT06844422) | Shandong Cancer Hospital and Institute | 2025-02-08 |
| Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema (NCT06845163) | Alexandria University | 2025-02-08 |
| Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC) (NCT06766825) | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2025-02-07 |
| Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate (NCT06798402) | Al-Mustafa University College | 2025-02-07 |
| The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction (NCT06732648) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2025-02-07 |
| Administration of Surfactant Through an Instillation Device Infasurf® (Calfactant) in Neonates- A Pilot Study (NCT04056741) | ONY | 2025-02-07 |
| Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus (NCT06886126) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2025-02-07 |
| A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC (NCT06785636) | Pathos AI, Inc. | 2025-02-07 |
| Oral-ATO for TP53-mutated Myeloid Malignancies (NCT06778187) | The University of Hong Kong | 2025-02-07 |
| Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations (NCT07117890) | Fudan University | 2025-02-07 |
| Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer (NCT06758700) | Shanghai Pulmonary Hospital, Shanghai, China | 2025-02-07 |
| Efficacy of Levofloxacin Versus Ciprofloxacin in the Treatment of Childhood Typhoid Fever (NCT07150065) | Avicenna Medical College Lahore | 2025-02-07 |
| Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544). (NCT06799351) | Bernardino Clavo, MD, PhD | 2025-02-07 |
| Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy (NCT06706544) | Bernardino Clavo, MD, PhD | 2025-02-07 |
| Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy (NCT06427798) | National Cancer Institute (NCI) | 2025-02-07 |
| OLIGO-10: Stereotactic Ablative Radiation Therapy for Metastatic Patients With 6 to 10 Metastatic Sites (NCT06856603) | National Medical Research Radiological Centre of the Ministry of Health of Russia | 2025-02-07 |
| Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia. (NCT06531018) | Renata PLC | 2025-02-07 |
| A Study of TAK-360 in Adults With Idiopathic Hypersomnia (NCT06812078) | Takeda | 2025-02-07 |
| AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF (NCT06793371) | Cytokinetics | 2025-02-06 |
| A Study Assessing HMB-002 in Participants With Von Willebrand Disease (NCT06754852) | Hemab ApS | 2025-02-06 |
| Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel (NCT06483555) | UNC Lineberger Comprehensive Cancer Center | 2025-02-06 |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine (NCT06754605) | Sinocelltech Ltd. | 2025-02-06 |
| Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE) (NCT06843239) | Zura Bio Inc | 2025-02-06 |
| A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder (NCT06817356) | Eli Lilly and Company | 2025-02-06 |
| Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer (NCT06617923) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2025-02-06 |
| Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI (NCT06678074) | Implicit Bioscience | 2025-02-06 |
| Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer (NCT06800313) | Janssen Research & Development, LLC | 2025-02-06 |
| Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types (NCT06782412) | KU Leuven | 2025-02-06 |
| Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial (NCT06632977) | Alliance for Clinical Trials in Oncology | 2025-02-06 |
| A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease (NCT06830629) | Maze Therapeutics | 2025-02-05 |
| Topical Probiotic Sinus Irrigations for Treating Chronic Sinusitis (NCT05427695) | University of Illinois at Chicago | 2025-02-05 |
| Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents (NCT06477653) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-02-05 |
| 61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET) (NCT06455358) | University Hospital, Basel, Switzerland | 2025-02-05 |
| Personalized Antisense Oligonucleotide for A Single Participant With UBTF Gene Mutation (NCT07588581) | n-Lorem Foundation | 2025-02-05 |
| BCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple Myeloma (NCT06793449) | Institute of Hematology & Blood Diseases Hospital, China | 2025-02-05 |
| Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma (NCT06563362) | University of Zurich | 2025-02-04 |
| Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral Miltefosine (NCT06550609) | Fundacion Nacional de Dermatologia | 2025-02-04 |
| BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS (NCT06704152) | BlueSphere Bio, Inc | 2025-02-04 |
| Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS) (NCT06802315) | University of Illinois at Chicago | 2025-02-04 |
| Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities (NCT06794996) | Vertex Pharmaceuticals Incorporated | 2025-02-04 |
| Combination COMBO Endoscopy Oropharyngeal Airway With High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese Patients (NCT06812403) | Zhejiang University | 2025-02-04 |
| Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis (NCT06954597) | Topadur Pharma AG | 2025-02-04 |
| A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors (NCT06618287) | Bristol-Myers Squibb | 2025-02-04 |
| COMBO Endoscopy Oropharyngeal Airway in Sedated Gastrointestinal Endoscopy for Obese Patients (NCT06804876) | Zhejiang University | 2025-02-04 |
| Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy (NCT07105384) | Fundacion Clinic per a la Recerca Biomédica | 2025-02-04 |
| Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS) (NCT06780293) | Taipei Veterans General Hospital, Taiwan | 2025-02-03 |
| Intravenous Dexmedetomidine as an Adjuvant to Locoregional Anesthesia in Pediatric Surgery (NCT06736483) | University Hospital, Montpellier | 2025-02-03 |
| Resistant Potato Starch to Alleviate GWI (NCT05820893) | VA Office of Research and Development | 2025-02-03 |
| Effect of Acetylcholinesterase Inhibitors on Bone Metabolism (NCT06041789) | Duke University | 2025-02-03 |
| Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder (NCT06547489) | Syndeio Biosciences, Inc | 2025-02-03 |
| Pulse Study: Peripheral Use of Low-dose Vasopressors for Safety and Efficacy in the Intensive Care Unit (NCT06920173) | Kingston Health Sciences Centre | 2025-02-03 |
| The Effect of Gum Arabic (GA) on Residual Renal Function in Adult Dialysis Patients in Abu Dhabi (NCT06836206) | Abu Dhabi Health Services Company | 2025-02-03 |
| Study Assessing Pain Relief After Replacement of the Knee (NCT06799845) | Allay Therapeutics, Inc. | 2025-02-03 |
| A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis (NCT06335888) | Insel Gruppe AG, University Hospital Bern | 2025-02-03 |
| Tirzepatide for Obesity and Meth Use Disorder (NCT06745128) | University of Texas Southwestern Medical Center | 2025-02-03 |
| Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD) (NCT06897839) | Airway Therapeutics, Inc. | 2025-02-03 |
| A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity (NCT06817863) | Drexel University | 2025-02-01 |
| Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer (NCT06736717) | University of Kansas Medical Center | 2025-02-01 |
| A Study of Enalapril in Treatment of Venous Malformations (NCT06788314) | Oslo University Hospital | 2025-02-01 |
| Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents (NCT06816771) | Shandong Cancer Hospital and Institute | 2025-02-01 |
| Fecal Microbiota Transplantation for Radiation-Induced Proctopathy (NCT06776029) | Sixth Affiliated Hospital, Sun Yat-sen University | 2025-02-01 |
| Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE) (NCT06791772) | Keymed Biosciences Co.Ltd | 2025-02-01 |
| Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia (NCT07010237) | Institute of Hematology & Blood Diseases Hospital, China | 2025-02-01 |
| Phase II Clinical Study of Vonorasan Fumarate Injection in the Treatment of Peptic Ulcer Bleeding (NCT06783257) | Shandong New Time Pharmaceutical Co., LTD | 2025-02-01 |
| Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma (NCT06845241) | Beijing InnoCare Pharma Tech Co., Ltd. | 2025-02-01 |
| Non-steroidal Anti-inflammatory Drugs in Pleurodesis (NCT06731647) | Centre Hospitalier Universitaire, Amiens | 2025-02-01 |
| Effect of Capivasertib on ctDNA in ER Positive Breast Cancer (NCT06613516) | Imperial College London | 2025-02-01 |
| Avapritinib Maintenance for AML With KIT Mutations (NCT06765915) | Ruijin Hospital | 2025-02-01 |
| Evaluating the Efficacy of the Combination of Multi-zonal Contact Lens and Atropine for Controlling Myopia Progression (NCT06765603) | Singapore National Eye Centre | 2025-02-01 |
| PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer (NCT06842472) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-02-01 |
| A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients (NCT06811870) | Guangdong Provincial People's Hospital | 2025-02-01 |
| Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia (NCT06560879) | National Institute of Pediatrics, Mexico | 2025-02-01 |
| Spinal Cord Stimulation for Freezing of Gait in Parkinson's Disease (NCT06798844) | Universitaire Ziekenhuizen KU Leuven | 2025-02-01 |
| Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer (NCT05539365) | Roswell Park Cancer Institute | 2025-02-01 |
| Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation (NCT05232032) | Mclean Hospital | 2025-02-01 |
| Study to Evaluate the Use of Capecitabine in Monotherapy and in Combination With Oxaliplatin in Elderly Patients as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer. (NCT06888843) | Nizhny Novgorod Regional Clinical Oncology Center | 2025-02-01 |
| Double Dose 4-AP on Functional Recovery After Spinal Cord Injury (NCT06853015) | Shirley Ryan AbilityLab | 2025-02-01 |
| Pharmacokinetics Safety and Acceptability of DRV/r for Children Living With HIV (NCT06139796) | PENTA Foundation | 2025-02-01 |
| Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury (NCT06723561) | Medical College of Wisconsin | 2025-02-01 |
| Systemic Antitumor Treatment with or Without Pressurized Intraperitoneal Aerosol Chemotherapy for Colon Peritoneal Metastases (PIPOX02) (NCT06681038) | Institut Cancerologie de l'Ouest | 2025-02-01 |
| Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) (NCT06563323) | Oregon Health and Science University | 2025-02-01 |
| Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia (NCT06147232) | Steno Diabetes Center Copenhagen | 2025-02-01 |
| Study of Olutasidenib and Temozolomide in HGG (NCT06161974) | Rigel Pharmaceuticals | 2025-02-01 |
| Treatment Options for Chronic Urticaria (NCT06816784) | Sheikh Zayed Medical College | 2025-02-01 |
| SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer. (NCT06835179) | The First Affiliated Hospital with Nanjing Medical University | 2025-02-01 |
| Leucine in Midlife Depression (NCT06580145) | Emory University | 2025-02-01 |
| Comparison of Low-Level Laser Therapy and Transcutaneous Electrical Nerve Stimulation for Myofascial Pain in Temporomandibular Disorders (NCT06790667) | University of Health Sciences Lahore | 2025-02-01 |
| A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer (NCT06745193) | Peking University | 2025-02-01 |
| A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC (NCT06793761) | Beijing Tongren Hospital | 2025-02-01 |
| Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma (NCT06757894) | Sun Yat-sen University | 2025-02-01 |
| Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses (NCT06338826) | ANRS, Emerging Infectious Diseases | 2025-02-01 |
| The Aim of Study is to Identify the Predictive Factors for the Success of Transforaminal Epidural Injection in Treatment of Patients with Lumbosacral Radiculopathy (NCT06795542) | Amr Mohamed Sedik | 2025-02-01 |
| Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy (NCT06809751) | Mohsen Pourazizi | 2025-02-01 |
| AZA Combined with R-GemOx for Elderly DLBCL Patients (NCT06778902) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2025-02-01 |
| Beneficial Effect of Silymarin in Ulcerative Colitis (NCT06213857) | Tanta University | 2025-02-01 |
| Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment (NCT06904599) | Hospital Universitario Dr. Jose E. Gonzalez | 2025-02-01 |
| Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer (NCT06784206) | Peking University Cancer Hospital & Institute | 2025-02-01 |
| ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID 19) (NCT05433181) | University of Pennsylvania | 2025-02-01 |
| A Study of SCTB35 in Patients with Systemic Lupus Erythematosus (NCT06841042) | Sinocelltech Ltd. | 2025-02-01 |
| Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma (NCT06805864) | Gunma University | 2025-02-01 |